Back to Search Start Over

Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.

Authors :
MASAMICHI HAYASHI
SUGURU YAMADA
NAO TAKANO
YUKIYASU OKAMURA
HIDEKI TAKAMI
YOSHIKUNI INOKAWA
FUMINORI SONOHARA
NOBUTAKE TANAKA
DAI SHIMIZU
NORIFUMI HATTORI
MITSURO KANDA
CHIE TANAKA
GORO NAKAYAMA
MASAHIKO KOIKE
YASUHIRO KODERA
Source :
In Vivo; May/Jun2021, Vol. 35 Issue 3, p1749-1760, 12p
Publication Year :
2021

Abstract

Background/Aim: Hepatocellular carcinoma (HCC) mainly develops in the damaged liver from hepatitis C virus (HCV) or hepatitis B virus (HBV) infection in Japan. On the other hand, the occurrence of HCCs derived from the liver without viral infection has recently been increasing. Our aim was to identify characteristics specific to HCCs with virus-infected liver (HCC-BC) or those with non-B- and non-C-infected liver (HCC-NBNC), Patients and Methods: We collected preoperative serum a-fetoprotein (AFP) and Des-Gamma-Carboxy Prothrombin (DCP), also known as PIVKA-II values from surgically resected HCC cases during 1994-2017 in our department. Results: Preoperative serum AFP values of HCC-BC cases (n=284) were higher compared to HCC-NBNC cases (n=88) (p=0.016), whereas serum DCP values of HCC-NBNC cases were higher compared to HCC-BC cases (p<0.001). Multivariable analyses indicated that abnormal serum AFP [hazard ratio (HR)=1.46, 95% conficdence interval (CI)=1 .03-2.07, p=0.035) was one of the significant recurrence-free survival predictors of HCC-BC cases, while abnormal serum DCP (HR=4.99, 95%C1=1.91-13.01, p=0.001) was one of the significant recurrence-free survival predictors of HCC-NBNC cases Conclusion: HCC-NBNC cases have a different tumor marker profile from HCC-BC cases. Elevated DCP could be both a diagnostic and prognostic marker of HCC-NBNC patients [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0258851X
Volume :
35
Issue :
3
Database :
Complementary Index
Journal :
In Vivo
Publication Type :
Academic Journal
Accession number :
150111584
Full Text :
https://doi.org/10.21873/invivo.12434